Vistin Pharma ASA (LTS:0RAM)
kr 27.6 0 (0%) Market Cap: 1.18 Bil Enterprise Value: 1.18 Bil PE Ratio: 19.84 PB Ratio: 3.90 GF Score: 72/100

Q2 2021 Vistin Pharma ASA Earnings Call Transcript

Apr 27, 2022 / 06:30AM GMT
Release Date Price: kr20.8
Operator

Good day, and thank you for standing by. Welcome to the Vistin Pharma ASA First Quarter 2022 Results Presentation Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Alexander Karlsen. Please go ahead.

Alexander Karlsen
Vistin Pharma ASA - CFO

Thank you. Good morning, everyone, and welcome to the presentation. As mentioned, today's presenters will be myself, Alexander Karlsen, the CFO; and Magnus Tolleshaug, the Chief Commercial Officer and the interim CEO.

I'm now handing the word over to you, Magnus, to start the presentation.

Magnus Tolleshaug
Vistin Pharma ASA - Interim CEO, Chief Commercial Officer & Commercial Director

Thank you, Alexander. I will go through the highlights of the first quarter 2022 results. The revenue in the first quarter ended at NOK 33 million versus NOK 71 million in Q1 2021. We had a decrease in revenue for the quarter,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot